Longevity Medicine in Newport Beach, California
Dr. Meena Verma, longevity physician in Newport Beach.
I built this practice for patients who expect more from medicine than the absence of disease.
Founder & Lead Longevity Physician
Dr. Meena Verma MD,MPH
Board-certified in Internal Medicine, Nephrology, Clinical Hypertension, and Obesity Medicine. Fellowship-trained at UC San Diego with advanced certifications in peptide therapy, age-management medicine, genomic interpretation (Stanford), and advanced hormone optimization.
Holding a Master’s in Public Health from the University of Iowa.
How I work
I’m Dr. Meena Verma, board-certified in internal medicine, nephrology, clinical hypertension, and obesity medicine. For more than 12 years I cared for patients with complex, advanced disease, often after the damage to the heart, kidneys, and blood vessels was already done. I started Blue Coast Longevity to work at the other end: finding and addressing risk years before it becomes disease.
I keep my practice intentionally small so I can work closely with every patient. We begin with extensive lab work, a DEXA scan, and fitness testing, followed by an in-person visit of more than an hour to go through it all together. From there, I build a plan aimed at the root causes of your risk. It may include medications, hormones, peptides, or other targeted therapies, but only where they make sense for you.
As we continue working together, we go deeper with advanced diagnostics: AI-guided Cleerly coronary imaging to assess cardiovascular risk, genomics, and blood-based cancer screening. I interpret every result with you and act on what we find.
You’ll have my direct line. If you’d rather work with a physician than follow a program, we should talk.
Precision Diagnostics & Cellular Health
Advanced biomarker panels, DEXA scans, VO₂ max testing, biological age scoring, AI-driven cardiac imaging & more — years before symptoms appear.
What We Actually Do
Advanced diagnostics, optimization, and longevity therapies — delivered six ways:
Hormone & Peptide Optimization
Physician-supervised protocols using pharmaceutical-grade peptides and bio-regulators to restore energy, cognition, libido, and recovery.
Injury Repair & Fitness
Regenerative therapies and performance coaching to heal faster and train smarter.
Cardiometabolic & Brain Health
Targeted interventions to protect your heart and sharpen your mind
Next-Gen Cancer Screening
Cutting-edge, non-invasive liquid biopsies and multi-cancer early detection.
Personalized Longevity Programs & More
Your custom blueprint with quarterly deep dives
Research & Publications
Dr. Verma has contributed to peer-reviewed research in metabolic health, cardiovascular outcomes in chronic diseases, systems biology, and related fields — foundational knowledge that directly informs modern longevity medicine. Her work emphasized early intervention in metabolic and inflammatory pathways to prevent decline, a principle that drives Blue Coast Longevity’s focus on optimizing biological age, hormone balance, and performance before symptoms arise.
Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: A meta-analysis. Balamuthusamy S, Verma M. American Heart Journal. 2008;155(5):791-805. (A key meta-analysis on protecting cardiovascular health in high-risk metabolic states — core to preventing age-related decline.)
Advances of Genomic Science and Systems Biology in Renal Transplantation: A Review. Perkins D, Verma M. Seminars in Immunopathology. 2011;33(2):211-218. (Exploring systems-level biology and genomics — insights that underpin today's precision approaches to aging and optimization.)
Impact of single immunosuppressive drug withdrawal on lymphocyte immunoreactivity. Verma M, Awadishu L. Journal of Surgical Research. 2014 May 1;188(1):309-15. (Investigating immune modulation — relevant to inflammation control and longevity strategies like peptide therapies.)
Practice patterns in screening and management of prostate cancer in elderly men Konety BR, Sharp VJ, Verma M. Urology. 2006;68(5):1051-1056. (Consensus work on age-related screening — highlighting proactive health management in aging populations.)
Invited Speaker & Key Presentations
Advanced Nephrology: Nephrology for the Consultant (2011) CPC: Case of Acute Kidney Injury in a Patient with Prostate Cancer (with David M Ward, MD, FRCP).
Study the Impact of TRPV1 inhibition on T cell function in vivo — Young Investigator's Forum, National Kidney Foundation, May 2012.
Acute Oxalate nephropathy from intravenous vitamin C therapy — Poster presentation, National Kidney Foundation 2011.
Angiotensin receptor blockade and cardiovascular outcomes in Diabetic Nephropathy Patients with Hypertension (Metanalysis) — American Society of Nephrology 2007.
Cardiac Troponin I has decreased Utility for Diagnosing Obstructive Coronary Artery Disease in Renal failure patients with Sub-optimal Blood Pressure Control — American Society of Hypertension 2007.
Enoxaparin induced skin necrosis: A case study — ACP Illinois Regional Chapter 2006.
Wernicke’s encephalopathy: A case study — ACP Illinois Regional Chapter 2006.
Screening and Management of Prostate Cancer in Elderly Men: the Iowa Prostate Cancer Consensus (participated in consensus meeting; presented at UICC World Cancer Congress).
These contributions reflect Dr. Verma’s deep-rooted commitment to evidence-based medicine and understanding complex metabolic/immunological systems. Today at Blue Coast Longevity, she applies these principles through advanced diagnostics (biological age testing, VO₂ max, DEXA trends), targeted interventions (peptides, hormone optimization, metabolic tracking), and personalized plans to help high-achievers maintain peak performance and reverse subtle declines — turning scientific insight into real-world longevity advantages.
A limited practice.
If you would like to begin a conversation, write. I read every inquiry myself.